MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Modeling the Effect of Patient’s Perception of Non-Motor and Motor Function on Parkinson’s Disease Severity

    C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)

    Objective: To develop optimal models of patients' perception of non-motor and motor function on objectively measured Parkinson's disease (PD) severity. Background: There is increased interest…
  • 2019 International Congress

    Tsallis entropy of EEG correlates with future cognitive decline in patients with Parkinson’s disease

    SM. Keller, A. Meyer, JG. Bogaarts, U. Gschwandtner, P. Fuhr, V. Roth (Basel, Switzerland)

    Objective: To evaluate whether Tsallis entropy (TE) constitutes a possible functional characterization of neurodegeneration and a measure to predict progression of Parkinson’s disease (PD). Background:…
  • 2019 International Congress

    How cognitive effort increases Parkinson’s tremor – an effictive connectivity fMRI study

    MF. Dirkx, H. Zach, A. van Nuland, BR. Bloem, I. Toni, R. Helmich (Nijmegen, Netherlands)

    Objective: To elucidate the neural mechanisms underlying tremor amplification during cognitive effort. Background: Parkinson’s tremor is related to cerebral activity in both basal ganglia and…
  • 2019 International Congress

    Motor and non-motor symptoms differences between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages

    R. Raimundo, M. Mendes, R. Jesus, C. Azoia, A. Almeida, AG. Velon (Vila Real, Portugal)

    Objective: Compare motor and non-motor symptoms between VP and PD patients. Background: VP is usually described as “lower-body parkinsonism”, with early gait difficulties and postural…
  • 2019 International Congress

    Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

    Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)

    Objective: To characterize olfactory impairment in Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Background: In the previous study, we found…
  • 2019 International Congress

    Impaired fonction of mirror neurons and the role of levodopa in PD patients

    T. Danaila, P. Jaulent, C. Laurencin, J. Xie, H. Klinger, P. Krolak-Salmon, S. Thobois (Lyon, France)

    Objective: Study of the emotional mirroring and its modulation by levodopa treatment in fluctuating PD patients with no significant cognitive burden as assessed by regular…
  • 2019 International Congress

    The utility of DCTclock™ (the digital clock drawing test) for unmasking early cognitive decline in Parkinson’s disease

    T. Schejter Margalit, R. Kizony, B. Cohen, A. Thaler, W. Souillard-Mandar, A. Holway, V. Irzhevsky, A. Orr-Urtreger, J. Cederbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the utility of DCTclock, for assessing subtle cognitive impairments in early Parkinson's disease (PD). Background: The identification of cognitive decline is crucial…
  • 2019 International Congress

    Lymphocyte Senescence in Parkinson’s Disease

    M. Jensen, K. Scott, M. Camacho, A. Kouli, R. Wijeyekoon, I. Solim, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To characterise T- and B-lymphocyte senescence in early stage Parkinson’s disease (PD). Background: Evidence suggests that the immune system may contribute to PD aetiopathogenesis,…
  • 2019 International Congress

    Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease

    X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)

    Objective: We aimed to explore the hypothesis that the PGC-1α variants are associated with its promoter methylations level thus affecting the PGC-1α mRNA expression. We…
  • 2019 International Congress

    Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain

    K. Methawasin, R. Suppawat, P. Petborom, M. Wongwandee, S. Rungruanghiranya, T. Asawavichienjinda (Ongkharak, Thailand)

    Objective: To find out phenotypes of movement disorders related to COPD, and also associated factors. Background: Movement disorders in systemic diseases exactly are common in…
  • « Previous Page
  • 1
  • …
  • 184
  • 185
  • 186
  • 187
  • 188
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • DaTscan in clinical evaluation of Multiple System Atrophy
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley